Enhanced in vivo gene expression mediated by listeriolysin O incorporated anionic LPDII: Its utility in cytotoxic T lymphocyte-inducing DNA vaccine

Journal of Controlled Release

Volumn 148, Issue 2, 2010, Pages 219-225

  Sun, Xun ^a,b   Provoda, Chester ^a   Lee, Kyung Dall ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

CTL response; DNA delivery; Listeriolysin O; LPDII; Vaccine

Indexed keywords

ANIONIC LIPOSOMES; BACTERIAL PROTEIN; CRITICAL ISSUES; CTL RESPONSE; CYTOTOXIC; CYTOTOXIC T LYMPHOCYTES; DELIVERY SYSTEMS; DNA COMPLEX; DNA DELIVERY; DNA VACCINATION; DNA VACCINE; GENE DELIVERY; IMMUNE RESPONSE; IN-VITRO; IN-VIVO; LISTERIOLYSIN O; LPDII; NON-VIRAL GENE DELIVERY; NONVIRAL VECTORS; OVALBUMINS; POLYCATIONS; POTENTIAL UTILITY; SPLENOCYTES; T-CELL RESPONSE; TRANSFECTION EFFICIENCY;

ANTIGENS; DNA; DRUG THERAPY; GENE THERAPY; GENE TRANSFER; VACCINES;

GENE EXPRESSION;

DNA VACCINE; GAMMA INTERFERON; LIPOSOME; LISTERIOLYSIN O; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IN VIVO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL;

ANIMALS; BACTERIAL TOXINS; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; IMMUNIZATION; INJECTIONS, INTRAVENOUS; INTERFERON-GAMMA; LIPOSOMES; MICE; MICE, INBRED C57BL; OVALBUMIN; POLYAMINES; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES, DNA;

EID: 78649323079     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.06.017     Document Type: Article

References (44)

1. Kawakami S., Higuchi Y., Hashida M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J. Pharm. Sci. 2008, 97(2):726-745.
2. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem. Rev. 2008, 109(2):259-302.
3. Shedlock D.J., Weiner D.B. DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol. 2000, 68(6):793-806.
4. Bivas-Benita M., Ottenhoff T.H., Junginger H.E., Borchard G. Pulmonary DNA vaccination: concepts, possibilities and perspectives. J. Control. Release 2005, 107(1):1-29.
5. Huygen K. Plasmid DNA vaccination. Microbes Infect. 2005, 7(5-6):932-938.
6. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., Jones T.R., Hobart P., Margalith M., Ng J., Weiss W.R., Sedegah M., de Taisne C., Norman J.A., Hoffman S.L. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998, 282(5388):476-480.
7. Frelin L., Sallberg M. A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans. Genome Med. 2009, 1(1):15.
8. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat. Rev. Genet. 2008, 9(10):776-788.
9. Khan A.S., Draghia-Akli R., Shypailo R.J., Ellis K.I., Mersmann H., Fiorotto M.L. A comparison of the growth responses following intramuscular GHRH plasmid administration versus daily growth hormone injections in young pigs. Mol. Ther. 2009, 18(2):327-333.
10. Bergman P.J., Camps-Palau M.A., McKnight J.A., Leibman N.F., Craft D.M., Leung C., Liao J., Riviere I., Sadelain M., Hohenhaus A.E., Gregor P., Houghton A.N., Perales M.A., Wolchok J.D. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 2006, 24(21):4582-4585.
11. Yoshikawa T., Imazu S., Gao J.Q., Hayashi K., Tsuda Y., Shimokawa M., Sugita T., Niwa T., Oda A., Akashi M., Tsutsumi Y., Mayumi T., Nakagawa S. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine. Biochem. Biophys. Res. Commun. 2004, 325(2):500-505.
12. Lee R.J., Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J. Biol. Chem. 1996, 271(14):8481-8487.
13. Shi G., Guo W., Stephenson S.M., Lee R.J. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J. Control. Release 2002, 80(1-3):309-319.
14. Banerjee R. Liposomes: applications in medicine. J. Biomater. Appl. 2001, 16(1):3-21.
15. Portnoy D.A., Auerbuch V., Glomski I.J. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J. Cell Biol. 2002, 158(3):409-414.
16. Choi S., Lee K.D. Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J. Control. Release 2008, 131(1):70-76.
17. Lee K.D., Oh Y.K., Portnoy D.A., Swanson J.A. Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes. J. Biol. Chem. 1996, 271(13):7249-7252.
18. Mandal M., Lee K.D. Listeriolysin O-liposome-mediated cytosolic delivery of macromolecule antigen in vivo: enhancement of antigen-specific cytotoxic T lymphocyte frequency, activity, and tumor protection. Biochim. Biophys. Acta 2002, 1563(1-2):7-17.
19. Mathew E., Hardee G.E., Bennett C.F., Lee K.D. Cytosolic delivery of antisense oligonucleotides by listeriolysin O-containing liposomes. Gene Ther. 2003, 10(13):1105-1115.
20. Saito G., Amidon G.L., Lee K.D. Enhanced cytosolic delivery of plasmid DNA by a sulfhydryl-activatable listeriolysin O/protamine conjugate utilizing cellular reducing potential. Gene Ther. 2003, 10(1):72-83.
21. Portnoy D.A., Jones S. The cell biology of Listeria monocytogenes infection (escape from a vacuole). Ann. NY Acad. Sci. 1994, 730:15-25.
22. Beauregard K.E., Lee K.D., Collier R.J., Swanson J.A. pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes. J. Exp. Med. 1997, 186(7):1159-1163.
23. Lorenzi G.L., Lee K.D. Enhanced plasmid DNA delivery using anionic LPDII by listeriolysin O incorporation. J. Gene Med. 2005, 7(8):1077-1085.
24. Ramshaw I.A., Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol. Today 2000, 21(4):163-165.
25. Li Y., Jin J., Yang Y., Bian Z., Chen Z., Fan M. Enhanced immunogenicity of an anti-caries vaccine encoding a cell-surface protein antigen of Streptococcus mutans by intranasal DNA prime-protein boost immunization. J. Gene Med. 2009, 11(11):1039-1047.
26. Tanghe A., D'Souza S., Rosseels V., Denis O., Ottenhoff T.H., Dalemans W., Wheeler C., Huygen K. Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting. Infect. Immun. 2001, 69(5):3041-3047.
27. Yu S., Feng X., Shu T., Matano T., Hasegawa M., Wang X., Ma H., Li H., Li Z., Zeng Y. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B. Vaccine 2008, 26(48):6124-6131.
28. Bartlett G.R. Phosphorus assay in column chromatography. J. Biol. Chem. 1959, 234(3):466-468.
29. Byers A.M., Kemball C.C., Moser J.M., Lukacher A.E. Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J. Immunol. 2003, 171(1):17-21.
30. Chen W., Huang L. Induction of cytotoxic T-lymphocytes and antitumor activity by a liposomal lipopeptide vaccine. Mol. Pharm. 2008, 5(3):464-471.
31. Weston S.A., Parish C.R. New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescence microscopy. J. Immunol. Meth. 1990, 133(1):87-97.
32. Juliano R.L. Factors affecting the clearance kinetics and tissue distribution of liposomes, microspheres and emulsions. Adv. Drug Deliv. Rev. 1988, 2(1):31-54.
33. Mumtaz S., Ghosh P.C., Bachhawat B.K. Design of liposomes for circumventing the reticuloendothelial cells. Glycobiology 1991, 1(5):505-510.
34. Li S., Huang L. In vivo gene transfer via intravenous administration of cationic lipid -protamine -DNA (LPD) complexes. Gene Ther. 1997, 4(9):891-900.
35. Li S., Rizzo M.A., Bhattacharya S., Huang L. Characterization of cationic lipid -protamine -DNA (LPD) complexes for intravenous gene delivery. Gene Ther. 1998, 5(7):930-937.
36. Eliyahu H., Servel N., Domb A.J., Barenholz Y. Lipoplex-induced hemagglutination: potential involvement in intravenous gene delivery. Gene Ther. 2002, 9(13):850-858.
37. Heinzerling L., Basch V., Maloy K., Johansen P., Senti G., Wuthrich B., Storni T., Kundig T.M. Critical role for DNA vaccination frequency in induction of antigen-specific cytotoxic responses. Vaccine 2006, 24(9):1389-1394.
38. Oldstone M.B. The role of cytotoxic T lymphocytes in infectious disease: history, criteria, and state of the art. Curr. Top. Microbiol. Immunol. 1994, 189:1-8.
39. Shimizu K., Thomas E.K., Giedlin M., Mule J.J. Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein. Cancer Res. 2001, 61(6):2618-2624.
40. Chen J., Wu Q., Yang P., Hsu H.C., Mountz J.D. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF. IX gene therapy. Mol. Ther. 2006, 13(2):260-269.
41. Xiao-wen H., Shu-han S., Zhen-lin H., Jun L., Lei J., Feng-juan Z., Ya-nan Z., Ying-jun G. Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting. Vaccine 2005, 23(14):1649-1656.
42. Yang K., Whalen B.J., Tirabassi R.S., Selin L.K., Levchenko T.S., Torchilin V.P., Kislauskis E.H., Guberski D.L. A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protection. J. Immunol. 2008, 180(9):6159-6167.
43. Zacharowski K., Zacharowski P.A., Koch A., Baban A., Tran N., Berkels R., Papewalis C., Schulze-Osthoff K., Knuefermann P., Zahringer U., Schumann R.R., Rettori V., McCann S.M., Bornstein S.R. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc. Natl Acad. Sci. USA 2006, 103(16):6392-6397.
44. Lu Y.-C., Yeh W.-C., Ohashi P.S. LPS/TLR4 signal transduction pathway. Cytokine 2008, 42(2):145-151.